Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 3 7Phase 1/2 3Phase 2/3 2Phase 1 2

Status

Completed 6Terminated 1

Sponsor Class

INDUSTRY 4NETWORK 3

Study Type

Interventional 7

Sponsor

Cancer Type

Other hematologic neoplasm 35Lymphoid 17Myeloid 7Genitourinary 7Classical hematology 4Breast 3Sarcoma 1Gynecologic 1

Conditions

Prostatic Neoplasms 7Pain 2Neoplasms 1

Interventions

Docetaxel 77Radiotherapy 73Prednisone 66Leuprolide 51Goserelin 49Gemcitabine 49Cisplatin 48bicalutamide 46enzalutamide 43Androgen Antagonists 36pembrolizumab 32Abiraterone Acetate 31Mitomycin 29acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 28Magnetic Resonance Spectroscopy 28Carboplatin 27Flutamide 25Nivolumab 24Triptorelin Pamoate 23Sunitinib 23apalutamide 22Radiation 22Doxorubicin 20darolutamide 19abiraterone 18Gonadotropin-Releasing Hormone 18cabozantinib 17atezolizumab 16Specimen Handling 16Radiosurgery 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 3 × Mitoxantrone × Genitourinary × Clear all
NCT00004124 2022-12-30

S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

SWOG Cancer Research Network

Phase 3 Completed
983 enrolled 13 charts
Genitourinary

Prostatic Neoplasms

NCT00003232 2020-04-03

Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer

Canadian Cancer Trials Group

Phase 3 Completed
227 enrolled
Genitourinary

Pain, Prostatic Neoplasms

NCT01522443 2018-05-23

COMET-2

Exelixis

Phase 3 Terminated
119 enrolled 21 charts
Genitourinary

Pain, Prostatic Neoplasms

NCT00004001 2014-02-25

S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

SWOG Cancer Research Network

Phase 3 Completed
770 enrolled
Genitourinary

Prostatic Neoplasms

NCT00003343 2012-08-08

Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer

Pfizer

Phase 3 Completed
525 enrolled
Genitourinary

Prostatic Neoplasms

NCT00436839 2012-07-09

Taxotere Prostate Cancer New Indication Registration Trial in China

Sanofi

Phase 3 Completed
228 enrolled
Genitourinary

Prostatic Neoplasms

NCT00417079 2011-03-10

TROPIC

Sanofi

Phase 3 Completed
755 enrolled 19 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡